"Riverside Regional Medical Center is the most comprehensive medical facility in the region, offering advanced diagnostics and emergency treatment when you need it most. We offer the Peninsula's only Level II Trauma Center and Neonatal Intensive Care Unit. We are also recognized as a Chest Pain Center and a Comprehensive Stroke Center. Our services include advanced treatment in neurosciences, heart and cancer. General Information: 757-594-2000 Patient Information: 757-594-2010 Emergency-Trauma Center: 757-594-2050"

During the past decade, Riverside Regional Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverside Regional Medical Center" #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Penumbra Inc." with 2 trials sponsored, "AltaRex" with 1 trials sponsored, "Angel Medical Systems" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Regional Medical Center" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator and "Knox Community Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Regional Medical Center" are "Atrial Fibrillation" (3 trials), "Acute Coronary Syndrome" (2 trials), "Heart Failure" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Riverside Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Riverside Regional Medical Center" are "Device" (6 trials), "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Azimilide Dihydrochloride" (2 trials), "Bupropion HCl ER" (1 trials), "Cisplatin" (1 trials) and "Digital Engagement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Regional Medical Center" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Riverside Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Riverside Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Riverside Regional Medical Center has several departments that took part in Clinical trials: "Peninsula Cancer Institute" - 75 trials, "Peninsula Cancer Institute-Gloucester" - 25 trials, "The Center for Excellence in Aging and Geriatric Health" - 7 trials, "Riverside Neurology Specialists" - 5 trials, "Riverside Shore Cancer Center" - 3 trials, "Riverside Cardiology Specialists" - 2 trials